Skip to content

Bioharvest Sciences Inc.

BHST· NasdaqCore metricsCIK 1723464

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026
Market cap
$39.67M
22.67M shares
Filings
137
$34.51M
FY 2025+37.0% FY25 yoy
-$11.14M
FY 2025N/M FY25 yoy
-$5.58M
FY 2025N/M FY25 yoy
-$9.58M
FY 2025derivedN/M FY25 yoy
—
—
—
$23.03M
FY 2025+863.4% FY25 yoy
$39.67M
—
1.1×
1.6×
-24.15%
—

FY2025 figures · derived

Price

$1.7574.56%$5.13past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$34.51MFY 2025
$34.51M0FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$34,508,000reported
FY 20242024-12-31$25,188,000reported
FY 20232023-12-31$12,672,000reported

Segments

Segments
Revenue by Segments, FY2023 to FY2025FY2023Products · FY2023 · $12.67MNorth America · FY2023 · $10.86MIsrael · FY2023 · $1.81MFY2024Products · FY2024 · $24.91MNorth America · FY2024 · $23.01MIsrael · FY2024 · $2.18MCDMO Services · FY2024 · $282.00KFY2025Products · FY2025 · $32.63MNorth America · FY2025 · $30.59MIsrael · FY2025 · $3.92MCDMO Services · FY2025 · $1.88M
LineFY2025ShareChange
Products$32.63M95%+31.0%
North America$30.59M89%+32.9%
Israel$3.92M11%+80.2%
CDMO Services$1.88M5.4%+566.0%
Total$34.51M

From the 40-F filed Mar 31, 2026BHST

Pharmaceutical preparations

Bioharvest Sciences Inc. is the 143rd largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Bioharvest Sciences Inc. · CIK 1723464 · Engraved from SEC EDGAR